Humphries KH, Mancini GBJ. Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: Are mechanistic considerations warranted in practice? Eur Heart J.  2017 May 19 epub ahead of print.

Tell us what you think

Your email address will not be published.